Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36 pseudogene 18 (RPL36P18) is a processed pseudogene related to the gene encoding ribosomal protein L36, which is a component of the large 60S ribosomal subunit[3][9][10]. Pseudogenes like RPL36P18 are non-protein-coding DNA sequences that resemble functional genes but typically lack the ability to encode functional proteins due to mutations or disruptions. RPL36P18 does not appear to encode a functional product and is not known to have a direct biological function or disease association. Unlike the protein-coding RPL36 gene, which is involved in ribosome assembly and protein synthesis[5][7], RPL36P18 does not participate in these processes, and there are no reports suggesting it functions as a therapeutic target or biomarker[3][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36 pseudogene 18 (RPL36P18).